Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

1(33.3%)

Phase 2

1(33.3%)

N/A

1(33.3%)

3Total

Phase 3(1)

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07123935Not ApplicableNot Yet Recruiting

Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

Role: collaborator

NCT06102915Completed

Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting

Role: lead

NCT03807037Phase 2Completed

Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

Role: collaborator

NCT02982590Phase 3Completed

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

Role: collaborator

All 4 trials loaded